Back to News Archive
Co-administration of repaglinide and clopidogrel (a CYP2C8 inhibitor) may lead to a significant decrease in blood glucose levels due to a drug-drug interaction. The concomitant use of repaglinide and clopidogrel is now contraindicated.
Important Safety Information for Repaglinide and clopidogrel. New Contraindication for Concomitant Use
This site is intended for an audience in Canada